Search
for
Sort by
Research 181–210 of 387
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Cutaneous Drug Reaction Case Reports
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- Application of Scaffold-Based Drug Delivery in Oral Cancer Treatment: A Novel Approach
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Dermoscopy of Chronic Radiation-Induced Dermatitis in Patients with Head and Neck Cancers Treated with Radiotherapy
- Prostatakarzinom
- Abnormal fingerprints and immigration delay disease
- Thomas Hindson and His Discovery of Ascorbic Acid to Treat Prickly Heat
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Redefining hormone resistance in prostate cancer
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Drug Reactions Affecting Hair: Diagnosis
- Female Pattern Hair Loss
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Management of Toxicities of Targeted Therapies
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Severe Unilateral Alopecia in a Long-Term Surviving Male Adolescent Glioblastoma Multiforme Patient
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- The PDGF/PDGFR pathway as a drug target
- Cutaneous drug reactions
- Lupus erythematosus: systemic and cutaneous manifestations
- Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years